NEWS
News Updates
Information Center
MA Achievement Release | Agomelatine Tablets Have Obtained Registration Approval!
2024-12-06
Congratulations to Chongqing Huasen Pharmaceutical Co., Ltd. on obtaining the registration certificate for the agomelatine tablet project.
MA Results Release | Huasen Pharmaceutical—Terazosin Hydrochloride Capsules Approved!
2022-03-23
Congratulations to Chongqing Huasen Pharmaceutical Co., Ltd. on receiving the “Drug Approval Notice” for its Terazosin Hydrochloride Capsules (2mg) project!
2021-02-23
Due to the company's growth, Eurasia Huizhi (Beijing) Medical Research Co., Ltd. officially established a Shanghai office on February 19, 2021.
A seminar on a clinical study protocol for non-small cell lung cancer was successfully held.
2021-01-05
During the period of regular COVID-19 prevention and control, our company successfully held an online proposal discussion meeting!
Uniting Hearts and Combining Forces: Otaikang’s Internal Training Successfully Held
2020-09-25
From June 2 to 3, 2018, the Aotekang Group held an internal training session in Beijing, themed “Unite Hearts and Pool Strengths to Secure a Winning Future.”
2020-09-24
On April 5, 2019, the kickoff meeting for the Phase I clinical trial of a Class 1.1 new chemical drug project, a well-known listed company's drug, was held. Eurasia Huizhi (Beijing) Medical Research Co., Ltd. served as the contract research organization for this project.
Leave a message for inquiry